Literature DB >> 19796970

Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation.

Shin Matsuoka1, George R Washko, Mark T Dransfield, Tsuneo Yamashiro, Raul San Jose Estepar, Alejandro Diaz, Edwin K Silverman, Samuel Patz, Hiroto Hatabu.   

Abstract

RATIONALE AND
OBJECTIVES: Pulmonary vascular alteration is one of the characteristic features of chronic obstructive pulmonary disease (COPD). Recent studies suggest that vascular alteration is closely related to endothelial dysfunction and may be further influenced by emphysema. However, the relationship between morphological alteration of small pulmonary vessels and the extent of emphysema has not been assessed in vivo. The objectives of this study are: to evaluate the correlation of total cross-sectional area (CSA) of small pulmonary vessels with the extent of emphysema and airflow obstruction using CT scans and to assess the difference of total CSA between COPD phenotypes.
MATERIALS AND METHODS: We measured CSA less than 5 mm(2) and 5-10 mm(2), and calculated the percentage of the total CSA for the lung area (%CSA < 5, and %CSA5-10, respectively) using CT scans in 191 subjects. The extent of emphysema (%LAA-950) was calculated, and the correlations of %CSA < 5 and %CSA5-10 with %LAA-950 and results of pulmonary function tests (PFTs) were evaluated. The differences in %CSA between COPD phenotypes were also assessed.
RESULTS: The %CSA < 5 had significant negative correlations with %LAA-950 (r = -0.83, P < .0001). There was a weak but statistically significant correlation of %CSA < 5 with forced expiratory volume in 1 second (FEV1)% predicted (r = 0.29, P < .0001) and FEV1/forced vital capacity (r = 0.45, P < .0001). A %CSA 5-10 had weak correlations with %LAA-950 and results of PFTs. %CSA < 5 was significantly higher in bronchitis phenotype than in the emphysema phenotype (P < .0001).
CONCLUSIONS: Total CSA of small pulmonary vessels at sub-subsegmental levels strongly correlates with the extent of emphysema (%LAA-950) and reflects differences between COPD phenotypes.

Entities:  

Mesh:

Year:  2009        PMID: 19796970      PMCID: PMC2790546          DOI: 10.1016/j.acra.2009.07.022

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  35 in total

1.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease.

Authors:  V I Peinado; J A Barberá; P Abate; J Ramírez; J Roca; S Santos; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  Endothelial dysfunction in pulmonary arteries of patients with mild COPD.

Authors:  V I Peinado; J A Barbera; J Ramirez; F P Gomez; J Roca; L Jover; J M Gimferrer; R Rodriguez-Roisin
Journal:  Am J Physiol       Date:  1998-06

3.  Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group.

Authors:  R T Tan; R Kuzo; L R Goodman; R Siegel; G B Haasler; K W Presberg
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

4.  Newer aspects of the pulmonary vasculature in chronic lung disease. A comparative study.

Authors:  E M Cordasco; F R Beerel; J W Vance; R W Wende; R R Toffolo
Journal:  Angiology       Date:  1968 Jul-Aug       Impact factor: 3.619

5.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema.

Authors:  P A Gevenois; V de Maertelaer; P De Vuyst; J Zanen; J C Yernault
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

6.  Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema.

Authors:  K A Hale; D E Niewoehner; M G Cosio
Journal:  Am Rev Respir Dis       Date:  1980-08

7.  Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.

Authors:  A T Dinh-Xuan; T W Higenbottam; C A Clelland; J Pepke-Zaba; G Cremona; A Y Butt; S R Large; F C Wells; J Wallwork
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

8.  Pulmonary scintigraphy in elastase-induced emphysema in pigs. Correlation with high-resolution computed tomography and histology.

Authors:  S Noma; G W Moskowitz; P G Herman; A Khan; K A Rojas
Journal:  Invest Radiol       Date:  1992-06       Impact factor: 6.016

9.  Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease.

Authors:  J A Barberà; A Riverola; J Roca; J Ramirez; P D Wagner; D Ros; B R Wiggs; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

10.  Relation of pulmonary vessel size to transfer factor in subjects with airflow obstruction.

Authors:  A W Musk
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

View more
  57 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in Smokers.

Authors:  Farbod N Rahaghi; J Michael Wells; Carolyn E Come; Isaac A De La Bruere; Surya P Bhatt; James C Ross; Gonzalo Vegas-Sánchez-Ferrero; Alejandro A Diaz; Jasleen Minhas; Mark T Dransfield; Raúl San José Estépar; George R Washko
Journal:  J Comput Assist Tomogr       Date:  2016 Nov/Dec       Impact factor: 1.826

3.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

Authors:  Raúl San José Estépar; Gregory L Kinney; Jennifer L Black-Shinn; Russell P Bowler; Gordon L Kindlmann; James C Ross; Ron Kikinis; Meilan K Han; Carolyn E Come; Alejandro A Diaz; Michael H Cho; Craig P Hersh; Joyce D Schroeder; John J Reilly; David A Lynch; James D Crapo; J Michael Wells; Mark T Dransfield; John E Hokanson; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

4.  How to Detect Tobacco-related Vasculopathy: Are We There Yet?

Authors:  Jarrod Barnes; Stefanie Krick
Journal:  Ann Am Thorac Soc       Date:  2019-06

5.  Quantitative CT Measures of Bronchiectasis in Smokers.

Authors:  Alejandro A Diaz; Thomas P Young; Diego J Maselli; Carlos H Martinez; Ritu Gill; Pietro Nardelli; Wei Wang; Gregory L Kinney; John E Hokanson; George R Washko; Raul San Jose Estepar
Journal:  Chest       Date:  2016-11-24       Impact factor: 9.410

6.  Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD.

Authors:  Alejandro A Diaz; Brian Bartholmai; Raúl San José Estépar; James Ross; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; John J Reilly; Edwin K Silverman; George R Washko
Journal:  Respir Med       Date:  2010-04-10       Impact factor: 3.415

Review 7.  The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.

Authors:  R Graham Barr
Journal:  Proc Am Thorac Soc       Date:  2011-11

Review 8.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

9.  Assessment of COPD severity by combining pulmonary function tests and chest CT images.

Authors:  Yukitaka Nimura; Takayuki Kitasaka; Hirotoshi Honma; Hirotsugu Takabatake; Masaki Mori; Hiroshi Natori; Kensaku Mori
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-12-07       Impact factor: 2.924

10.  Preoperative pulmonary vascular morphology and its relationship to postpneumonectomy hemodynamics.

Authors:  Farbod N Rahaghi; Daniel Lazea; Saba Dihya; Raúl San José Estépar; Raphael Bueno; David Sugarbaker; Gyorgy Frendl; George R Washko
Journal:  Acad Radiol       Date:  2014-06       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.